Oyster Point Pharma Announces Publication in Ophthalmology of ONSET-2 Phase 3 Data on TYRVAYAᵀᴹ (varenicline solution) Nasal Spray

NEXT STORY
Global Neurological Therapies Market Research Report 2021: Competitive Landscape and Pipeline Analysis Focusing Specifically on Therapeutic Interventions for Neurodegenerative Diseases
PREV STORY
atai Life Sciences Reports Third Quarter 2021 Financial Results and Corporate Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Zai Lab Announces Pricing of Public Offering of American Depositary Shares and Ordinary Shares

author_avatar
NASDAQ Market News

Distribution of Zoetis’ products in Sweden, Denmark and Norway by Orion to end after 2020

author_avatar
NASDAQ Market News

Veru Sets Another Quarterly Record in Both Net Revenues and in Gross Profit for Fiscal 2021 Third Quarter

author_avatar
NASDAQ Market News